Thematic section: Natural compounds Open access

Cytotoxic activity of the crude extract and derived fractions from the sea anemone Telmatactis panamensis against cancer cell lines

Authors

Published
22 April 2025
Section
Thematic section: Natural compounds
DOI
10.4081/jbr.2025.12720

Abstract

Sea anemones are considered a source of bioactive compounds with important pharmacological properties. In this study, we assessed the cytotoxic activity of Telmatactis panamensis and derived gel filtration fractions against the MCF-7 breast cancer and C6 rat glioma cell lines. The crude extract induced a concentrationand time-dependent response, reducing the viability of C6 cells from 38.76 to 1.90% with concentrations of 50–500 μg/mL at 24 h and from 11.81 to 0.73% at 48 h. In MCF-7 cells, the extract reduced viability from 61.71 to 20% and from 12.07 to 0.61% at 24 and 48 h, respectively. Fraction 1 provoked the highest cytotoxic activity in the C6 cell line, followed by fraction 3 and fraction 2. Lower sensitivity to the fractions was shown in MCF-7 cells, with only fraction 3 reducing viability by up to 50%. Both the extract and the fractions displayed low or no cytotoxicity in the normal breast cell line Hs 578Bst, suggesting that they present selectivity towards breast cancer cells over normal cells. The results support that T. panamensis represents a potential source for the discovery of biologically active compounds against tumor cell lines.

Keywords

References

  1. Madio B, King GF, Undheim EAB. Sea anemone toxins: a structural overview. Mar Drugs 2019;17:325. DOI: https://doi.org/10.3390/md17060325
  2. Frazão B, Vasconcelos V, Antunes A. Sea anemone (Cnidaria, Anthozoa, Actiniaria) toxins: an overview. Mar Drugs 2012;10:1812-51. DOI: https://doi.org/10.3390/md10081812
  3. Lanio ME, Morera V, Alvarez C, et al. Purification and characterization of two hemolysins from Stichodactyla helianthus. Toxicon 2001;39:187-94. DOI: https://doi.org/10.1016/S0041-0101(00)00106-9
  4. Marino A, Morabito R, La Spada G. Factors altering the haemolytic power of crude venom from Aiptasia mutabilis (Anthozoa) nematocysts. Comp Biochem Physiol A Mol Integr Physiol 2009;152:418-22. DOI: https://doi.org/10.1016/j.cbpa.2008.11.016
  5. Cline EI, Wiebe LI, Young JD, Samuel J. Toxic effects of the novel protein UpI from the sea anemone Urticina piscivora. Pharmacol Res 1995;32:309-14. DOI: https://doi.org/10.1016/S1043-6618(05)80020-9
  6. Díaz A, Tejuca M, Alvarez C, et al. Anticoagulant effect of total extract and some fractions obtained from the sea anemone Stichodactyla helianthus. Revista Iberoamericana de Trombosis y Homeostasis 1992;5:8-11.
  7. Thangaraj S, Bragadeeswaran S, Suganthi K, Kumaran NS. Antimicrobial properties of sea anemone Stichodactyla mertensii and Stichodactyla gigantea from Mandapam coast of India. Asian Pac J Trop Biomed 2011;1:S43–6. DOI: https://doi.org/10.1016/S2221-1691(11)60120-2
  8. Tejuca M, Anderluh G, Maček P, et al. Antiparasite activity of sea-anemone cytolysins on Giardia duodenalis and specific targeting with anti-Giardia antibodies. Int J Parasitol 1999;29:489-98. DOI: https://doi.org/10.1016/S0020-7519(98)00220-3
  9. Soletti RC, de Faria GP, Vernal J, et al. Potentiation of anticancer-drug cytotoxicity by sea anemone pore-forming proteins in human glioblastoma cells. Anticancer Drugs 2008;19:517-25. DOI: https://doi.org/10.1097/CAD.0b013e3282faa704
  10. Fedorov S, Dyshlovoy S, Monastyrnaya M, et al. The anticancer effects of actinoporin RTX-A from the sea anemone Heteractis crispa (=Radianthus macrodactylus). Toxicon 2010;55:811-7. DOI: https://doi.org/10.1016/j.toxicon.2009.11.016
  11. Ramezanpour M, da Silva KB, Sanderson BJ. The effect of sea anemone (H. magnifica) venom on two human breast cancer lines: death by apoptosis. Cytotechnology 2014;66:845-52. DOI: https://doi.org/10.1007/s10616-013-9636-5
  12. Tejuca M, Anderluh G, Dalla Serra M. Sea anemone cytolysins as toxic components of immunotoxins. Toxicon 2009;54:1206-14. DOI: https://doi.org/10.1016/j.toxicon.2009.02.025
  13. Suput D. In vivo effects of cnidarian toxins and venoms. Toxicon 2009;54:1190-200. DOI: https://doi.org/10.1016/j.toxicon.2009.03.001
  14. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74:229-63. DOI: https://doi.org/10.3322/caac.21834
  15. Nobili S, Lippi D, Witort E, et al. Natural compounds for cancer treatment and prevention. Pharmacol Res 2009;59:365-78. DOI: https://doi.org/10.1016/j.phrs.2009.01.017
  16. Barreca M, Spanò V, Montalbano A, et al. Marine anticancer agents: An overview with a particular focus on their chemical classes. Mar Drugs 2020;18:619. DOI: https://doi.org/10.3390/md18120619
  17. Patra S, Praharaj PP, Panigrahi DP, et al. Bioactive compounds from marine invertebrates as potent anticancer drugs: the possible pharmacophores modulating cell death pathways. Mol Biol Rep 2020;47:7209-28. DOI: https://doi.org/10.1007/s11033-020-05709-8
  18. Avila AD, de Acosta CM, Lage A. A new immunotoxin built by linking a hemolytic toxin to a monoclonal antibody specific for immature T lymphocytes. Int J Cancer 1988;42:568-71. DOI: https://doi.org/10.1002/ijc.2910420417
  19. Pederzolli C, Belmonte G, Serra MD, et al. Biochemical and cytotoxic properties of conjugates of transferrin with equinatoxin II, a cytolysin from a sea anemone. Bioconjug Chem 1995;6:166-73. DOI: https://doi.org/10.1021/bc00032a003
  20. Soto C, Bergado G, Blanco R, et al. Sticholysin II-mediated cytotoxicity involves the activation of regulated intracellular responses that anticipates cell death. Biochimie 2018;148:18-35. DOI: https://doi.org/10.1016/j.biochi.2018.02.006
  21. Acuña FH, González-Muñoz R, Garese A, Díaz-Ferguson E. First records of Anthopleura nigrescens (Verrill, 1928) and Telmatactis panamensis (Verrill, 1869) (Cnidaria, Anthozoa, Actiniaria) from Parque Nacional Coiba, Pacifc coast of Panama. Check List 2022;18:1141–6. DOI: https://doi.org/10.15560/18.5.1141
  22. Prentis PJ, Pavasovic A, Norton RS. Sea anemones: quiet achievers in the field of peptide toxins. Toxins 2018;10:36. DOI: https://doi.org/10.3390/toxins10010036
  23. Verrill, AE. Review of the polyps of the west coast of America. Trans Conn Acad Arts Sci 1869;1:377-558. DOI: https://doi.org/10.5962/bhl.title.38651
  24. Kem WR, Parten B, Pennington MW, et al. Isolation, characterization, and amino acid sequence of a polypeptide neurotoxin occurring in the sea anemone Stichodactyla helianthus. Biochemistry 1989;28:3483-9. DOI: https://doi.org/10.1021/bi00434a050
  25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54. DOI: https://doi.org/10.1006/abio.1976.9999
  26. Chiba K, Kawakami K, Tohyama K. Simultaneous evaluation of cell viability by neutral red, MTT and crystal violet staining assays of the same cells. Toxicol In Vitro 1998;12:251-8. DOI: https://doi.org/10.1016/S0887-2333(97)00107-0
  27. Repetto G, del Peso A, Zurita JL. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc 2008;3:1125-31. DOI: https://doi.org/10.1038/nprot.2008.75
  28. Librizzi M, Martino C, Mauro M, et al. Natural anticancer peptides from marine animal species: evidence from in vitro cell model systems. Cancers 2023;16:36. DOI: https://doi.org/10.3390/cancers16010036
  29. Mariottini GL, Pane L. Cytotoxic and cytolytic cnidarian venoms. A review on health implications and possible therapeutic applications. Toxins 2013;6:108-51. DOI: https://doi.org/10.3390/toxins6010108
  30. Horváth S. Cytotoxicity of drugs and diverse chemical agents to cell cultures. Toxicology 1980;16:59-66. DOI: https://doi.org/10.1016/0300-483X(80)90110-9
  31. Ramezanpour M, Burke da Silva K, Sanderson B. Differential susceptibilities of human lung, breast and skin cancer cell lines to killing by five sea anemone venoms. J Venom Anim Toxins Incl Trop Dis 2012;18:157–63. DOI: https://doi.org/10.1590/S1678-91992012000200005
  32. Monroy-Estrada HI, Chirino YI, Soria-Mercado IE, et al. Toxins from the Caribbean sea anemone Bunodeopsis globulifera increase cisplatin-induced cytotoxicity of lung adenocarcinoma cells. J Venom Anim Toxins Incl Trop Dis 2013;19:12. DOI: https://doi.org/10.1186/1678-9199-19-12
  33. Cutignano A, Nuzzo G, Ianora A, et al. Development and application of a novel SPE-method for bioassay-guided fractionation of marine extracts. Mar Drugs 2015;13:5736-49. DOI: https://doi.org/10.3390/md13095736
  34. Riccio G, Martinez KA, Martín J, et al. Jellyfish as an alternative source of bioactive antiproliferative compounds. Mar Drugs 2022;20:350. DOI: https://doi.org/10.3390/md20060350
  35. Moghadasi Z, Shahbazzadeh D, Jamili S, et al. Significant anticancer activity of a venom fraction derived from the Persian Gulf sea anemone, Stichodactyla haddoni. Iran J Pharm Res 2020;19:402-20.
  36. Freshney RI. Culture of animal cells: a manual of basic technique and specialized. 6th ed. Hoboken, NJ: John Wiley & Sons; 2010. DOI: https://doi.org/10.1002/9780470649367
  37. Hendrich AB, Michalak K. Lipids as a target for drugs modulating multidrug resistance of cancer cells. Curr Drug Targets 2003;4:23-30. DOI: https://doi.org/10.2174/1389450033347172

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

Copyright (c) 2025 the Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.